Indication

For the treatment of adult patients with moderate to severe limbal stem cell deficiency (defined by the presence of superficial corneal neovascularisation in at least two corneal quadrants, with central corneal involvement, and severely impaired visual acuity) due to physical or chemical ocular burns. A minimum of 1-2 mm2 of undamaged limbus is required for biopsy.

Medicine details

Medicine name:
ex vivo expanded autologous human corneal epithelial cells containing stem cells (Holoclar)
SMC ID:
SMC2261
Pharmaceutical company
Chiesi Limited
BNF chapter
Eye
Submission type
Full
Publication due date:
07 September 2020